[{"arm_notes": "", "treatment_id": null, "treatment_name": "Patients in this study are treated with intravenous tociluzumab: 8 mg/kg (maximum dose 800 mg); which can be repeated at the same dose after 8 hours if the hypoxia has not improved. This is the approved dose for cytokine release syndrome.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Patients in this study are treated with intravenous tociluzumab: 8 mg/kg (maximum dose 800 mg); which can be repeated at the same dose after 8 hours if the hypoxia has not improved. This is the approved dose for cytokine release syndrome.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]